Canada and US clear St Jude's transseptal access tool:
This article was originally published in Clinica
Executive Summary
The ACross transseptal access system, a device designed to improve an electrophysiologist's ability to access the left atrium during complex cardiac procedures has been approved for sale in both the US and Canada, said its manufacturer, St Jude Medical. The St Paul, Minnesota-based firm designed the device to increase control and reduce the complexity of reaching the chamber during treatments such as atrial fibrillation ablation.